Alisha Holtzhausen

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy”.

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Journal of Clinical Investigation(2020)10.1172/jci133055

N/A

0DataRank · unranked

251 citations

Kathy S. Evans, Nicholas C. DeVito, Michael P. Plebanek, Michael Sturdivant, Luke P. Wachsmuth +10 more

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell Reports(2021)10.1016/j.celrep.2021.109071

N/A

0DataRank · unranked

82 citations

Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama +6 more

Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis

Cancers(2021)10.3390/cancers13194753

N/A

0DataRank · unranked

18 citations

Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael P. Plebanek, Nicholas C. DeVito +2 more

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Science Translational Medicine(2022)10.1126/scitranslmed.abq7019

N/A

0DataRank · unranked

55 citations

Nagendra Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira +8 more

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.26.538456

N/A

0DataRank · unranked

3 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen +5 more

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

Science Immunology(2024)10.1126/sciimmunol.adi4191

N/A

0DataRank · unranked

126 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, X F Wang, Alisha Holtzhausen +4 more

MERTK Inhibition as a Targeted Novel Cancer Therapy

International Journal of Molecular Sciences(2024)10.3390/ijms25147660

N/A

0DataRank · unranked

13 citations

Alisha Holtzhausen, Aashis Thapa, Justus M. Huelse, Douglas K. Graham, H. Shelton Earp +1 more

MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0666

N/A

0DataRank · unranked

6 citations

George M. Edwards, Debra M. Hunter, H. Shelton Earp, Alisha Holtzhausen, Eden Y. Zewdie

MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression

UNC Libraries(2024)10.17615/2v44-5k13

N/A

0DataRank · unranked

0 citations

Yixuan Zhang, Yufei Jiang, Peng Liu, Nikolay V. Dokholyan, Chunhai Fan +13 more

MERTK Inhibition as a Targeted Novel Cancer Therapy

UNC Libraries(2024)10.17615/q9p8-mz87

N/A

0DataRank · unranked

0 citations

Alisha Holtzhausen, Douglas K. Graham, Aashis Thapa, H. Shelton Earp, K.M. Tanim +1 more

PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-0335

N/A

0DataRank · unranked

1 citations

Paran Goel, Oluwagbemiga A. Ojo, Katarina Moretto, Alisha Holtzhausen, Angel Humphryes +11 more